Amsterdam UMC becomes the first hospital in Europe to implant a double wireless pacemaker

Triumph for patients in Europe

Amsterdam UMC’s Heart Centre has become the first hospital in Europe to complete a double wireless pacemaker operation. This cutting-edge system uses two mini pacemakers, located in the lower and upper (atrium and ventricle) chambers of the heart, which synchronise with each other through electrical pulses.

Best for patients

The first pacemaker was fitted in 1958 in Sweden and since then procedures for cardiac issues have come a long way. Conventional pacemakers have a box implanted under the collarbone, with wires running through a vein to the heart. Unfortunately, these wires are fragile and can break, detach, or become infected, sometimes leading to repeat surgeries. Ten years ago, a mini pacemaker roughly the size of a vitamin, was introduced.

With around one million people receiving a pacemaker every year– this wireless technique has proved even better for patients. One in ten patients develop complications due to the wires that run through the bloodstream, for example due to a blockage of blood vessels. This new wireless pacemaker is inserted through the groin, both minimising the risk of infection and preventing scarring on the chest. Professor Reinoud Knops who together with Cardiologist Louise Olde Nordkamp installed the new pacemaker said: "We are delighted with the successful implantation of this advanced technology. The patient is doing well and we see this operation as an important advance in the treatment of many subsequent heart patients.’’

Amsterdam leading in matters of the heart

Amsterdam UMC’s Heart Centre has made several cardiovascular breakthroughs that not only impact on a national scale but also globally. In 2023, Amsterdam UMC began researching and developing AI-based algorithms to predict the likelihood of heart attacks due to arterial narrowing, this research is said to reduce postoperative complications for patients.

Alongside this Amsterdam’s UMC genetic research is identifying what drugs can benefit cardiovascular diseases, with successful results leading to a more personalised approach for patients for effective care. With the double wireless pacemaker having recently received CE approval (which certifies that a product has met the EU health, safety and environmental requirements) – this means that patients not only in the Netherlands but across Europe will benefit from this life-changing technological advancement.

Read more about how Amsterdam is meeting key healthcare challenges.